119 related articles for article (PubMed ID: 28238133)
1. qFlow Cytometry-Based Receptoromic Screening: A High-Throughput Quantification Approach Informing Biomarker Selection and Nanosensor Development.
Chen S; Weddell J; Gupta P; Conard G; Parkin J; Imoukhuede PI
Methods Mol Biol; 2017; 1570():117-138. PubMed ID: 28238133
[TBL] [Abstract][Full Text] [Related]
2. Absolute Quantification of Plasma Membrane Receptors Via Quantitative Flow Cytometry.
Fang Y; Malik M; England SK; Imoukhuede PI
Methods Mol Biol; 2022; 2475():61-77. PubMed ID: 35451749
[TBL] [Abstract][Full Text] [Related]
3. High Throughput Flow Cytometry for Cell Surface Profiling.
Paterson J; Ailles LE
Methods Mol Biol; 2018; 1678():111-138. PubMed ID: 29071678
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of protein kinase C enhances angiogenesis induced by platelet-derived growth factor C in hyperglycemic endothelial cells.
Moriya J; Ferrara N
Cardiovasc Diabetol; 2015 Feb; 14():19. PubMed ID: 25849290
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers in Pharmaceutical Research.
Zhao X; Modur V; Carayannopoulos LN; Laterza OF
Clin Chem; 2015 Nov; 61(11):1343-53. PubMed ID: 26408531
[TBL] [Abstract][Full Text] [Related]
6. A high-throughput fluorescence resonance energy transfer (FRET)-based endothelial cell apoptosis assay and its application for screening vascular disrupting agents.
Zhu X; Fu A; Luo KQ
Biochem Biophys Res Commun; 2012 Feb; 418(4):641-6. PubMed ID: 22290227
[TBL] [Abstract][Full Text] [Related]
7. Receptor occupancy assessment by flow cytometry as a pharmacodynamic biomarker in biopharmaceutical development.
Liang M; Schwickart M; Schneider AK; Vainshtein I; Del Nagro C; Standifer N; Roskos LK
Cytometry B Clin Cytom; 2016 Mar; 90(2):117-27. PubMed ID: 26054054
[TBL] [Abstract][Full Text] [Related]
8. Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling.
Zhou X; Yue GG; Liu M; Zuo Z; Lee JK; Li M; Tsui SK; Fung KP; Sun H; Pu J; Lau CB
Oncotarget; 2016 Dec; 7(50):82820-82835. PubMed ID: 27756875
[TBL] [Abstract][Full Text] [Related]
9. Moving pictures: imaging flow cytometry for drug development.
Elliott GS
Comb Chem High Throughput Screen; 2009 Nov; 12(9):849-59. PubMed ID: 19929790
[TBL] [Abstract][Full Text] [Related]
10. Implementation of highly sophisticated flow cytometry assays in multicenter clinical studies: considerations and guidance.
Sommer U; Morales J; Groenewegen A; Müller A; Naab J; Woerly G; Kamphausen E; Marsot H; Bennett P; Kakkanaiah V; Vitaliti A
Bioanalysis; 2015; 7(10):1299-311. PubMed ID: 26045007
[TBL] [Abstract][Full Text] [Related]
11. High concentrations of uric acid inhibit angiogenesis via regulation of the Krüppel-like factor 2-vascular endothelial growth factor-A axis by miR-92a.
Yu S; Hong Q; Wang Y; Hou K; Wang L; Zhang Y; Fu B; Zhou Y; Zheng W; Chen X; Wu D
Circ J; 2015; 79(11):2487-98. PubMed ID: 26299712
[TBL] [Abstract][Full Text] [Related]
12. Dual blockade of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) exhibits potent anti-angiogenic effects.
Li D; Xie K; Zhang L; Yao X; Li H; Xu Q; Wang X; Jiang J; Fang J
Cancer Lett; 2016 Jul; 377(2):164-73. PubMed ID: 27130666
[TBL] [Abstract][Full Text] [Related]
13. Proliferating and quiescent human umbilical vein endothelial cells (HUVECs): a potential in vitro model to evaluate contrast agents for molecular imaging of angiogenesis.
Vag T; Schramm T; Kaiser WA; Hilger I
Contrast Media Mol Imaging; 2009; 4(4):192-8. PubMed ID: 19672844
[TBL] [Abstract][Full Text] [Related]
14. Evidence of a sophisticatedly heterogeneous population of human umbilical vein endothelial cells.
Zheng YW; Nie YZ; Tsuchida T; Zhang RR; Aoki K; Sekine K; Ogawa M; Takebe T; Ueno Y; Sakakibara H; Hirahara F; Taniguchi H
Transplant Proc; 2014 May; 46(4):1251-3. PubMed ID: 24815173
[TBL] [Abstract][Full Text] [Related]
15. Application of flow cytometry for biomarker-based cervical cancer cells detection.
Ling J; Wiederkehr U; Cabiness S; Shroyer KR; Robinson JP
Diagn Cytopathol; 2008 Feb; 36(2):76-84. PubMed ID: 18181189
[TBL] [Abstract][Full Text] [Related]
16. Cell-Surface MMP-9 Protein Is a Novel Functional Marker to Identify and Separate Proangiogenic Cells from Early Endothelial Progenitor Cells Derived from CD133(+) Cells.
Kanayasu-Toyoda T; Tanaka T; Kikuchi Y; Uchida E; Matsuyama A; Yamaguchi T
Stem Cells; 2016 May; 34(5):1251-62. PubMed ID: 26824798
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of angiogenic cellular processes and claudin-5 by histamine and VEGF via PI3K-signaling, transcription factor SNAI2 and interleukin-8.
Laakkonen JP; Lappalainen JP; Theelen TL; Toivanen PI; Nieminen T; Jauhiainen S; Kaikkonen MU; Sluimer JC; Ylä-Herttuala S
Angiogenesis; 2017 Feb; 20(1):109-124. PubMed ID: 27873103
[TBL] [Abstract][Full Text] [Related]
18. A novel imaging-based high-throughput screening approach to anti-angiogenic drug discovery.
Evensen L; Micklem DR; Link W; Lorens JB
Cytometry A; 2010 Jan; 77(1):41-51. PubMed ID: 19834964
[TBL] [Abstract][Full Text] [Related]
19. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
Zhang JT; Fan YZ; Chen CQ; Zhao ZM; Sun W
Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632
[TBL] [Abstract][Full Text] [Related]
20. miR-342-5p Is a Notch Downstream Molecule and Regulates Multiple Angiogenic Pathways Including Notch, Vascular Endothelial Growth Factor and Transforming Growth Factor β Signaling.
Yan XC; Cao J; Liang L; Wang L; Gao F; Yang ZY; Duan JL; Chang TF; Deng SM; Liu Y; Dou GR; Zhang J; Zheng QJ; Zhang P; Han H
J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26857067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
